Skip to main content
. 2017 Oct 25;6(8):876–885. doi: 10.1530/EC-17-0293

Table 2.

Histopathological results of resected pNETs.

≤2 cm >2 cm All P (≤2 vs >2)
n 66 161 227
Surgery
 Whipple’sa 31 (47%) 52 (32%) 83 (37%) 0.015
 Distal pancreatectomy 30 (45%) 103 (64%) 133 (59%)
 Enucleation 5 (8%) 3 (2%) 8 (4%)
 Other 0 3 (2%) 3 (1%)
Liver resection 2 (3%) 29 (18%) 31 (14%) 0.002**
30-day mortality 0 4 (2%) 4 (2%) 0.325
Margin
 R0 53 (88%) 115 (79%) 168 (82%) 0.549
 R1 5 (8%) 20 (14%) 25 (12%)
 R2 2 (3%) 10 (7%) 12 (6%)
Diameter 14.7 (5) 51.8 (33) 40.4 (32) <0.001***
Local invasion 12 (18%) 117 (73%) 129 (57%) <0.001***
Vascular invasion 9 (14%) 61 (38%) 70 (31%) <0.001***
Nodal metastasis 13 (20%) 70 (43%) 83 (37%) <0.001***
Lymph node ratiob
 0 51 (77%) 79 (49%) 130 (57%) 0.001**
 0–0.2 1 (2%) 10 (6%) 11 (5%)
>0.2 3 (5%) 27 (17%) 30 (13%)
ENETS stage
 I 39 (59%) 0 39 (17%) <0.001***
 II 6 (9%) 57 (35%) 63 (28%)
 III 11 (17%) 43 (27%) 54 (24%)
 IV 10 (15%) 60 (37%) 70 (31%)
Malignantc features 25 (38%) 140 (87%) 165 (73%) <0.001***
Ki67% 4 (5) 10 (17) 8.01 (15) 0.004**
WHO 2010 grade
 G1 ≤2% 42 (64%) 62 (39%) 104 (46%) 0.002**
 G2 3–20% 20 (30%) 67 (42%) 87 (38%)
 G3>20% 2 (3%) 24 (15%) 26 (11%)
CgAd elevated 4 (24%) 26 (47%) 30 (42%) 0.122
Metachronous metastases 1 (2%) 18 (18%) 19 (8%) 0.01*

aWhipple’s category includes pylorus-preserving pancreatoduodenectomies and duodenum preserving pancreatectomies; blymph node ratio = positive nodes/nodes sampled; cmalignant features are defined as local invasion, vascular invasion, lymph node metastasis or distant metastasis (synchronous or metachronous); dCgA = chromogranin A. *P < 0.05. **P < 0.005.